9.60
price down icon1.54%   -0.15
after-market アフターアワーズ: 9.56 -0.04 -0.42%
loading

Immatics N V (IMTX) 最新ニュース

pulisher
Jan 06, 2026

Immatics price target raised to $17 from $14 at BofA - TipRanks

Jan 06, 2026
pulisher
Jan 06, 2026

BofA Adjusts Price Target on Immatics to $17 From $14, Maintains Buy Rating - marketscreener.com

Jan 06, 2026
pulisher
Jan 05, 2026

Immatics (NASDAQ:IMTX) Stock Price Down 8.8%What's Next? - MarketBeat

Jan 05, 2026
pulisher
Jan 04, 2026

Bank Watch: Will Immatics NV Equity Warrant stock deliver consistent dividendsJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - moha.gov.vn

Jan 04, 2026
pulisher
Jan 03, 2026

Immatics (NASDAQ:IMTX) Upgraded at Wall Street Zen - Defense World

Jan 03, 2026
pulisher
Jan 02, 2026

Immatics (NASDAQ:IMTX) Stock Price Up 3.9% – Should You Buy? - Defense World

Jan 02, 2026
pulisher
Dec 31, 2025

Aug Analyst Calls: Why Immatics NV Equity Warrant stock could be next big winnerWeekly Profit Report & High Accuracy Trade Signal Alerts - moha.gov.vn

Dec 31, 2025
pulisher
Dec 31, 2025

Immatics (NASDAQ:IMTX) Trading Up 3.9%Time to Buy? - MarketBeat

Dec 31, 2025
pulisher
Dec 29, 2025

Analysis Recap: Why Immatics N.V. stock is rated strong buy2025 Market Trends & Step-by-Step Trade Execution Guides - moha.gov.vn

Dec 29, 2025
pulisher
Dec 29, 2025

Aug Final Week: Why Immatics NV stock remains on buy lists2025 Risk Factors & Long Hold Capital Preservation Tips - moha.gov.vn

Dec 29, 2025
pulisher
Dec 29, 2025

Retail Surge: Is Immatics NV stock a top pick in earnings seasonTrade Performance Summary & Weekly Stock Breakout Alerts - moha.gov.vn

Dec 29, 2025
pulisher
Dec 27, 2025

Aug Drivers: Is Immatics NV stock a top pick in earnings seasonQuarterly Profit Summary & Daily Growth Stock Tips - moha.gov.vn

Dec 27, 2025
pulisher
Dec 27, 2025

(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Dec 27, 2025
pulisher
Dec 25, 2025

Immatics: PRAME Leader's Transition To Commercial Reality - Seeking Alpha

Dec 25, 2025
pulisher
Dec 21, 2025

Why Immatics N.V. Equity Warrant stock appeals to dividend seekersTrend Reversal & Smart Allocation Stock Reports - Улправда

Dec 21, 2025
pulisher
Dec 21, 2025

Is Immatics N.V. (4A3) stock a top dividend aristocrat candidate2025 Short Interest & Weekly Top Stock Performers List - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Aug Final Week: Can Immatics N.V. stock attract ESG capital inflowsWeekly Trade Review & Community Verified Swing Trade Signals - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why hedge funds are buying Immatics N.V. stock2025 Buyback Activity & Reliable Entry Point Trade Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Why Immatics N.V. stock is rated strong buyJuly 2025 Weekly Recap & Weekly Top Stock Performers List - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

Mizuho Securities Sticks to Their Buy Rating for Immatics (IMTX) - The Globe and Mail

Dec 20, 2025
pulisher
Dec 19, 2025

Why Immatics N.V. stock is considered a top pickTrade Exit Report & Community Verified Watchlist Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Why Immatics N.V. (4A3) stock trades below fair valueJuly 2025 Price Swings & AI Optimized Trading Strategy Guides - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

How Immatics N.V. Equity Warrant stock performs in rate cut cyclesM&A Rumor & Risk Adjusted Buy and Sell Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How Immatics N.V. Equity Warrant stock reacts to Fed rate cutsInsider Selling & Comprehensive Market Scan Insights - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How buybacks impact Immatics N.V. stock valueShort Setup & High Accuracy Trade Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Can Immatics N.V. (4A3) stock test all time highsJuly 2025 Levels & Low Risk Investment Opportunities - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

How Immatics N.V. Equity Warrant stock compares to market leadersJuly 2025 Short Interest & Growth Oriented Trading Recommendations - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Immatics N.V. stock a top pick in earnings seasonMarket Risk Report & Entry Point Strategy Guides - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Bearish Setup: Why Immatics N.V. Equity Warrant stock could see breakout soonMarket Performance Summary & Capital Efficiency Focused Strategies - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Will Immatics N.V. Equity Warrant stock continue upward momentumJuly 2025 Earnings & Intraday High Probability Setup Alerts - DonanımHaber

Dec 19, 2025
pulisher
Dec 18, 2025

Why Immatics N.V. Equity Warrant stock could see breakout soonWeekly Trade Review & Precise Trade Entry Recommendations - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Is Immatics N.V. Equity Warrant stock a buy for dividend growthIndex Update & Reliable Intraday Trade Alerts - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

New Highs: Can Immatics N.V. stock attract ESG capital inflowsWeekly Stock Recap & Verified Swing Trading Watchlists - Улправда

Dec 18, 2025
pulisher
Dec 18, 2025

Immatics appoints industry veteran as CFO - MSN

Dec 18, 2025
pulisher
Dec 17, 2025

How Immatics’ US$125 Million Follow-on Equity Raise At Immatics (IMTX) Has Changed Its Investment Story - simplywall.st

Dec 17, 2025
pulisher
Dec 16, 2025

Immatics completes $116.5 million share offering to boost R&D - MSN

Dec 16, 2025
pulisher
Dec 16, 2025

(IMTX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Dec 16, 2025
pulisher
Dec 14, 2025

Immatics N.V. (NASDAQ:IMTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Dec 14, 2025
pulisher
Dec 11, 2025

Immatics (IMTX) Updates on Promising IMA203CD8 Cell Therapy Tria - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Immatics presents IMA203CD8 PRAME cell therapy data at ESMO-IO Congress - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

Immatics Reveals Promising Results from IMA203CD8 Phase 1a Trial - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

Immatics Announces Promising Phase 1a Dose Escalation Results for IMA203CD8, a Second-Generation PRAME Cell Therapy for Advanced Solid Tumors - Quiver Quantitative

Dec 11, 2025
pulisher
Dec 11, 2025

Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress - FinanzNachrichten.de

Dec 11, 2025
pulisher
Dec 09, 2025

Is Immatics NV a good long term investmentMorning Star Patterns & Breakthrough Stock Performance - earlytimes.in

Dec 09, 2025
pulisher
Dec 09, 2025

A look into Immatics N.V (IMTX)’s deeper side - setenews.com

Dec 09, 2025
pulisher
Dec 09, 2025

Immatics Completes $116.5 Million Share Offering to Boost R&D - The Globe and Mail

Dec 09, 2025
pulisher
Dec 07, 2025

Immatics announces offering of 12.5M ordinary shares - MSN

Dec 07, 2025
pulisher
Dec 06, 2025

How Investors Are Reacting To Immatics (IMTX) $125 Million Follow-On Equity Offering - simplywall.st

Dec 06, 2025
pulisher
Dec 05, 2025

Finance Watch: Biotech Investors Take FDA Turmoil In Stride - Citeline News & Insights

Dec 05, 2025
pulisher
Dec 05, 2025

Immatics (NASDAQ:IMTX) Trading Up 8.9%Time to Buy? - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Immatics Down Nearly 15%, on Pace for Largest Percent Decrease Since October 2024 -- Data Talk - 富途牛牛

Dec 05, 2025
pulisher
Dec 05, 2025

Immatics announces $125 million underwritten offering - marketscreener.com

Dec 05, 2025
pulisher
Dec 05, 2025

Immatics Announces $125 Million Underwritten Offering - TradingView — Track All Markets

Dec 05, 2025
pulisher
Dec 05, 2025

Perhaps timely catching Immatics N.V (IMTX) would be a good idea - Setenews

Dec 05, 2025
pulisher
Dec 05, 2025

Immatics Plans $125 Million Stock Offering - marketscreener.com

Dec 05, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
大文字化:     |  ボリューム (24 時間):